2m 2m 2m 2m 2m 2m 2m
ANI Pharmaceutic (ANIP)
NASDAQ
$70.88-$0.21 (-0.30%)
Price as of Nov 12, 2026 8:34 AM EST- $1.6BMarket Cap
- -18.54%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ANI Pharmaceutic (ANIP)
$70.88-$0.21 (-0.30%)
ANIP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $71.09 | ||
Change | -$0.16 (-0.22%) | ||
Open | $70.87 | ||
High | $72.24 | ||
Low | $70.38 | ||
Previous Close | $71.25 | ||
Volume | 1,011,691 | ||
30-Day Average Volume | 446,913 | ||
1-Week Change | -0.78% | ||
1-Month Change | -3.79% | ||
1-Year Change | -18.54% | ||
3-Year Change | 36.29% | ||
5-Year Change | 56.86% | ||
Fundamentals | |||
Shares Outstanding | 22.7M | ||
Total Assets | $1.6B | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $290.8M | ||
Net Income | $35.1M | ||
Free Cash Flow | $70.3M | ||
EBIT | $52.1M | ||
EBITDA | $71.6M | ||
Net Working Capital | $574.1M | ||
EPS | $1.51 | ||
Enterprise Value/EBITDA | 21 | ||
Enterprise Value/Revenue | 5 | ||
P/B | 3 | ||
P/E | 47 | ||
PEG | 1 | ||
Price/Free Cash Flow | 23 | ||
Price/Operating Cash Flow | 19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/04/2012 | ||
Earnings & Revenue